AST TIRN research grant request for proposals
The AST Transplantation and Immunology Research Network (TIRN) research grants program supports fellows, junior faculty, and allied health professionals by funding innovative research in basic, clinical, and translational science. A limited number of grants will be awarded for research projects beginning July 1, 2016. The request for proposals is open now at www.TIRN.org/funding. Applications must be completed by 11:59 p.m. Pacific Standard Time on Sunday, Nov. 1, 2015. For more information, visit www.TIRN.org or email TIRN@myAST.org.
| Share this article:
Education and Clinical Tools for the ILDA: Webinar Sept. 16
"Basics of Informed Consent for Living Donors" is the next webinar in the Education and Clinical Tools for the Independent Living Donor Advocate (ILDA) webinar series, and takes place Wednesday, Sept. 16 at 1 p.m. EDT. The entire nine-webinar series, developed by the AST Live Donor Community of Practice, is free to AST members and their associates: just register with an AST member username and password at www.myAST.org/ILDA.
QAPI Adverse Events: Webinar Sept. 9
Join us and ASTS on Wednesday, Sept. 9, 2015 at Noon ET for the next installment of a monthly webinar series designed and presented by CMS. This webinar provides a brief look at some of the Basic Statistical Tools that may be utilized to conduct QA PI activities and a reference list of alternative tools/methods being used today. Register here!
You care about your transplant
patients. And so do we. That’s
why we’re introducing Astellas
Cares—a new program that
offers you customized tools,
educational resources, and
comprehensive support to help
your patients care for their
health. To register, visit
UPCOMING EVENTS IN TRANSPLANTATION
Surrogate Endpoints for Clinical Trials in Kidney Transplantation Public Workshop
Sept. 28, 2015 | Arlington, VA
For more information: http://www.fda.gov/Drugs/NewsEvents/ucm449248.htm
ASHI 41st Annual Meeting
Sept. 28 - Oct. 2, 2015 | Savannah, GA
For more information: http://www.ashi-hla.org/events/annual-meeting/
2015 Banff/CST Joint Meeting
Oct. 5-10, 2015 | Vancouver
For more information: http://www.cst-transplant.ca/meetings_asm.html
Society for Transplant Social Workers
Oct. 7-9, 2015 | Columbus, OH
For more information: https://www.stsw.org/conference/
ASN Kidney Week
Nov. 3-8, 2015 | San Diego, CA
For more information: https://www.asn-online.org/education/kidneyweek/
AASLD Liver Week
Nov. 13-17, 2015 | San Francisco, CA
For more information: http://www.aasld.org/events-professional-development/liver-meeting
CEOT 2016 – Cutting Edge of Transplantation
Feb. 25-27, 2016 | Phoenix, AZ
For more information: http://2016.ceot.myast.org/
The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
Where the sun shines: Industry's payments to transplant surgeons
American Journal of Transplantation
The Open Payments Program (OPP) was recently implemented to publicly disclose industry payments to physicians, with the goal of enabling patient awareness of potential conflicts of interests. Awareness of OPP, its data, and its implications for transplantation are critical. We used the first wave of OPP data to describe industry payments made to transplant surgeons. Transplant surgeons (N = 297) received a total of $759,654.
Outcomes of pregnancy following liver transplantation: The King's College Hospital experience
Liver Transplantation via PubMed
Reports of pregnancy in liver transplantation (LT) patients have largely favorable outcomes. Concerns remain with regards to maternal and graft risk, optimal immunosuppression (IS), and fetal outcomes. We review all post-LT pregnancies at our center with regard to the outcomes and safety for the patient, graft, and fetus. A total of 117 conceptions occurred in 79 patients.
Rates of kidney transplantation from living and deceased donors for blacks and whites in the United States, 1998 to 2011
JAMA Internal Medicine
This database review found that by 2010 the incidence of kidney transplantation for black and white patients with end-stage renal disease was equivalent, but kidney transplants from living donors were 43.2 percent for whites and only 22.2 percent for blacks. Kidney transplantation, the treatment standard for patients with end-stage renal disease (ESRD), is associated with prolonged survival, improved quality of life, reduced morbidity, and lower health care costs compared with dialysis.
Coronary events in obese hemodialysis patients before and after renal transplantation
We examined the impact of obesity (BMI greater than or equal to 30 kg/m2, n=357) on prognosis in 1696 hemodialysis (HD) patients before and after renal transplantation (TX). End-points were coronary events, composite CV events, and death. Obese HD patients were older (55.9 ± 9.2 v 54.2 ± 11), had more diabetes (54 percent v 40 percent), dyslipidemia (49 percent v 30 percent), altered myocardial scan (38 percent v 31 percent), MI (16 percent v 10 percent), coronary intervention (11 percent v 7 percent), higher total-cholesterol (186 ± 52 v 169 ± 47), and triglycerides (219 ± 167 v 144 ± 91).
VTI’s disposable intraoperative Doppler probes are ready to verify technical results.
There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes.
Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.
Hyponatremia, hypo-osmolality, and seizures in children early post-kidney transplant
Post-transplant seizures are uncommon in young kidney transplant recipients but can be harbingers of devastating outcomes such as cerebral edema and death. We reviewed all transplants performed at our institution from January 2013 to January 2014 and compared three patients who seized within 24 h post-transplant (cases) with the remaining 33 transplant recipients (controls). Records were reviewed for hyponatremia, hypocalcemia, hypomagnesemia, BUN clearance, osmolality shifts, and blood pressure control in the first 24 h post-transplant.
A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era
Knowledge of risk factors for posttransplant complications is likely to improve patient outcomes. Few large studies of all early postoperative complications after deceased donor liver transplantation (DDLT) exist. Therefore, we conducted a retrospective, cohort study of 30-day complications, their risk factors, and the impact on outcomes after DDLT. Three centers contributed data for 450 DDLTs performed from January 2005 through December 2009. Data included donor, recipient, transplant, and outcome variables. All 30-day postoperative complications were graded by the Clavien-Dindo system.